In Vivo Sustained Release of siRNA from Solid Lipid Nanoparticles
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Small interfering RNA (siRNA) is a highly potent drug in gene-based therapy with a challenge of being delivered in a sustained manner. Nanoparticle drug delivery systems allow for incorporating and controlled release of therapeutic payloads. We demonstrate that solid lipid nanoparticles can incorporate and provide sustained release of siRNA. Tristearin solid lipid nanoparticles, made by nanoprecipitation, were loaded with siRNA (4.4-5.5 wt % loading ratio) using a hydrophobic ion pairing approach that employs the cationic lipid DOTAP. Intradermal injection of these nanocarriers in mouse footpads resulted in prolonged siRNA release over a period of 10-13 days. In vitro cell studies showed that the released siRNA retained its activity. Nanoparticles developed in this study offer an alternative approach to polymeric nanoparticles for encapsulation and sustained delivery of siRNA with the advantage of being prepared from physiologically well-tolerated materials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · cited 1×
“Lipids and PEG moieties on the nanoparticle surface are used to stabilize nanoparticle dispersion; moreover, PEGylated NPs have prolonged circulation times in vivo, as well as reduced immunogenicity.(39) The resulting SLNPs have diameters of ∼150 nm as determined by scanning electron microscopy (SEM, Figure 2a).”
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages
Yu, W., Liu, C., Liu, Y., Zhang, N., & Xu, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0149-z · Cited by 137 · cited 9×
“(a) SEM images of SLNPs. (b) Cumulative release rate of siRNA from SLNPs. Line 1, 5.5 wt % of K6a_513a.12 siRNA; during the NP preparation the receiver solution contained an additional 0.5 wt % of PF 68, which had no effect on NP size.”
Influential
Cited by
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Shen, D., Yang, J., Li, X., Zhou, L., Zhang, R., Li, W., Chen, L., Wang, R., Zhang, F., & Zhao, D. (2014) · Nano Letters · doi:10.1021/nl404316v · Cited by 813
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Deng, Z. J., Morton, S. W., Ben-Akiva, E., Dreaden, E. C., Shopsowitz, K. E., & Hammond, P. T. (2013) · ACS Nano · doi:10.1021/nn4047925 · Cited by 516
Geszke-Moritz, M., & Moritz, M. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.119 · Cited by 392
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
Yonezawa, S., Koide, H., & Asai, T. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.022 · Cited by 378
RNA interference-based therapy and its delivery systems
Chen, X., Mangala, L. S., Rodriguez-Aguayo, C., Kong, X., Lopez-Berestein, G., & Sood, A. K. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9717-6 · Cited by 329
Assessment of PEG on polymeric particles surface, a key step in drug carrier translation
Rabanel, J.-M., Hildgen, P., & Banquy, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.017 · Cited by 318
Solid lipid nanoparticles for hydrophilic drugs
Mirchandani, Y., Patravale, V. B., & S., B. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.032 · Cited by 273
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
Gulino, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s23696 · Cited by 258
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Moazzam, M., Zhang, M., Hussain, A., Yu, X., Huang, J., & Huang, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.005 · Cited by 230
Yang, Y., Liu, F., Liu, X., & Xing, B. (2013) · Nanoscale · doi:10.1039/c2nr32835f · Cited by 229
Desai, P. R., Marepally, S., Patel, A. R., Voshavar, C., Chaudhuri, A., & Singh, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.021 · Cited by 188
“After the addition, organic solvent was allowed to evaporate for 4–12 h under stirring leading to nano-precipitation [33].”
Metadata
- Authors
- Lobovkina, T., Jacobson, G. B., Gonzalez-Gonzalez, E., Hickerson, R. P., Leake, D., Kaspar, R. L., Contag, C. H., & Zare, R. N.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-11-18
- Volume
- 5
- Issue
- 12
- Pages
- 9977-9983
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2026674730
- Cited by
- 139
- References
- 4
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.